Idarucizumab is now available as an antidote for dabigatran. Please refer to the highlighted clinical guides, clinical tools, and resources below for further information. Please note, that Thrombosis Canada in partnership with Think Research has developed a Bleed Management patient order set.
New/Novel Oral Anticoagulants (NOACs): Management of Bleeding
We have also updated our Perioperative Anticoagulant Management Algorithm and Bleed Management Clinical Tools to incorporate idarucizumab. Find these through the Clinical Tools tab on the homepage, or click here.
Emergency Management and Antidotes
Anticoagulant-related Bleeding Management Order Sets
Click here to access the Anticoagulant-related Bleeding Management Order Sets.